The U.S. Food and Drug Administration on Thursday proposed excluding active ingredients for Novo Nordisk and Eli Lilly’s weight-loss drugs on the list of drugs outsourcing facilities can use for compounding. If finalized, the exclusion would limit compounding of these…[#item_full_content]
Russia’s shadow war is putting Europe on edge as Germany confronts a growing threat
Settembre 6, 2026
Germany is pushing European partners to create a rapid-response task force in the Baltic Sea region as Berlin confronts what it says is an escalating
